Risk stratification of triple-negative breast cancer with core gene signatures associated with chemoresponse and prognosis

Authors:

Abstract
Neoadjuvant chemotherapy studies have consistently reported a strong correlation between pathologic response and long-term outcome in triple-negative breast cancer (TNBC). We aimed to define minimal gene signatures for predicting chemoresponse by a three-step approach and to further develop a risk-stratification method of TNBC.
Funding Information
  • National Research Foundation of Korea (2015R1A2A2A01008264)
  • National Research Foundation of Korea (2015R1A4A1041219)

This publication has 58 references indexed in Scilit: